Réadaptation en maladie pulmonaire obstructive chronique et en transplantation d'organes solides


Tania Janaudis-Ferreira

School of Physical and Occupational Therapy - McGill University


Domaine : Santé circulatoire et respiratoire

Programme chercheurs-boursiers - Junior 1

Concours 2016-2017

Dr. Janaudis-Ferreira's research program is aimed at improving care and rehabilitation results of 1) people with chronic lung disease and 2) people who have undergone organ transplants (heart, lung, liver, pancreas or kidney transplants). Although these two groups of patients may have different chronic diseases, they experience similar disorders as a consequence of their disease such as reduced capacity to exercise and decreased muscle strength. These disorders can affect their quality of life and independence during day-to-day life and, more importantly, put them at risk for heart diseases and early death. In the next four years, Dr. Janaudis-Ferreira will conduct five interlinking and unique research studies to address these problems and find the best rehabilitation treatments for these patients. Her first research study will look at preferences of patients with chronic lung disease for non-pharmacologic treatments including rehabilitation after a worsening of their symptoms.

The second study will look at whether patients' preferred choice of exercise is as effective as a standard hospital-based rehabilitation program. In the third study, she will summarize and analyze the findings of published studies that looked at the effects of exercise training for transplant patients to inform research and clinical practice. The fourth study will be a national survey to characterize the type of disability that Canadian transplant patients experience and how they use rehabilitation services in Canada. Finally, her fifth study will look at how feasible a home-based rehabilitation program is for transplant patients in Canada. The findings of her studies have the potential to inform future rehabilitation programs, policy and practice in chronic lung disease and organ transplantation.